Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4–insufficient subjects

Charlotte Schwab, Annemarie Gabrysch, Peter Olbrich, +77

Journal of Allergy and Clinical Immunology

Clinical ImmunologyAllergyLymphocyte DevelopmentMedicineImmunodeficiencies +10

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

François-Xavier Lescure, Hitoshi Honda, Robert Fowler, +289

The Lancet Respiratory Medicine

Therapeutic options for CTLA-4 insufficiency

David Egg, Ina Caroline Rump, Noriko Mitsuiki, +72

Journal of Allergy and Clinical Immunology

Translational MedicineCtla-4 InsufficiencyAutoimmune DiseaseImmunosuppressive TherapyImmunology +6

Efficacy and safety of thalidomide in patients with inflammatory manifestations of chronic granulomatous disease: A retrospective case series

Nicolas Noël, Nizar Mahlaoui, Stéphane Blanche, +14

Journal of Allergy and Clinical Immunology

RheumatologyChronic Granulomatous DiseaseGranulocyteInflammatory ManifestationsRetrospective Case Series +4

Clinical Value of Complement Activation Biomarkers in Overt Diabetic Nephropathy

Karyne Pelletier, Arnaud Bonnefoy, Hugo Chapdelaine, +5

Kidney International Reports

Increase in <i>de novo</i> food allergies after pediatric liver transplantation: Tacrolimus vs. cyclosporine immunosuppression

M. Lebel, Hugo Chapdelaine, Louis Paradis, +2

Pediatric Transplantation

Food AllergyAllergy MedicineImmunologyTransplantation MedicineChildhood Food Allergy +18

RETRACTED AND REPLACED: Real-World Effectiveness of Nirmatrelvir/Ritonavir on Coronavirus Disease 2019–Associated Hospitalization Prevention: A Population-based Cohort Study in the Province of Quebec, Canada

Jean‐Luc Kaboré, Benoît Laffont, Mamadou Diop, +10

Clinical Infectious Diseases

Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair^®)

Jason D. Hughes, T. Olynyc, Hugo Chapdelaine, +3

Clinical and Experimental Dermatology

Clinical and functional spectrum of RAC2-related immunodeficiency

Ágnes Donkó, Svetlana Sharapova, Juraj Kabát, +43

Blood

Partial Purine Nucleoside Phosphorylase Deficiency Helps Determine Minimal Activity Required for Immune and Neurological Development

Eyal Grunebaum, Nicholas J. Campbell, Matilde Leon‐Ponte, +2

Frontiers in Immunology